Cargando…
Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
The aim of this study was to determine the maximum tolerated dose of a fixed dose of docetaxel when combined with continuous infusion ifosfamide, with and without G-CSF support, in the treatment of advanced cancer, and to evaluate anti-tumour activity of this combination. Thirty-one patients with ad...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376167/ https://www.ncbi.nlm.nih.gov/pubmed/12373597 http://dx.doi.org/10.1038/sj.bjc.6600542 |